Who we are
Illumina is a leading developer, manufacturer, and marketer of life science tools andintegrated systems dedicated to making genomics useful for all. Innovating at theintersection of technology, biology, and health, we are reimagining what’s possible for humanhealth and the health of our planet, including how diseases—from cancer to COVID-19—arediscovered, detected, diagnosed, and treated. We provide sequencing innovations that areenabling researchers and clinicians to usher in the future of personalized medicine.

Fast facts

Founded in

Number of employees

Core annual revenue (2023)

1998

~9250

$4.43B USD

Net sequencing
installed base

> 21,000

Headquarters

Countries served

Chief Executive Officer

San Diego, California, USA> 160

Jacob Thaysen

Sequencing systems
Next-generation sequencing (NGS) is revolutionizing research, enabling experiments that weren’t possible before.
Illumina offers a range of innovative NGS platforms that deliver exceptional data quality and accuracy, at a massive scale.

MiSeq™ i100/i100 Plus

NovaSeq™
X/X Plus

NovaSeq
NextSeq™
6000/6000Dx* 1000/2000

Production-scale systems

NextSeq 550/550Dx*MiSeqMiSeqDx*

MiniSeq™ iSeq™ 100

Benchtop systems

Illumina Connected Software
Integrating seamlessly with our sequencing systems, Illumina Connected Software supports genomic and clinical researchers
from primary through tertiary analysis and optimizes lab and sample management. It offers the most accurate and comprehensive
variant calling with DRAGEN™ 4.2 secondary analysis,† powering greater applications and discovery. Balancing approachability withcustomization, Illumina Connected Software enables insights for single-sample or population-wide studies.
For Research Use Only. Not for use in diagnostic procedures.
*For In Vitro Diagnostic Use. Not available in all regions and countries.
†As compared against all participating solutions’ F1 score using PrecisionFDA v2 Truth Challenge Benchmark Data; Illumina internal data on
file for DRAGEN v4.2 software, data not from Illumina provided by Precision FDA v2 Truth Challenge 2020.

Applications

Customers• Oncology• Microbial genomics• Clinics• Government agencies• Genetic disease• Reproductive health• Hospitals• Infectious disease• Molecular and cell biology• Research labs

• Pharmaceuticalcompanies• Multiomics• Agriculture• Healthcare systems• Drug discovery• Conservation andsustainability• Academic institutions

Cost of sequencing per human whole genome
2001$100 million USD

2023

Since 2001, the cost of DNA sequencing
has dropped more than 100,000× from$100 million USD per human genome to$200 USD list price.

2$200 USD3

Where we operate
United States
San Diego(headquarters)

Foster City
Hayward
Baltimore
MadisonAustralia

Melbourne

Austria
ViennaBelgium

Brussels
MechelenBrazil

India

China

ItalySão Paulo
BeijingShanghai
Guangzhou
HangzhouNanjing
Taipei CityFranceÉvryRennes

Germany

Bengaluru
MilanIsrael

South Korea

Tel Aviv

SeoulJapanTurkey

TokyoOsaka

Istanbul

Eindhoven

Dubai

Singapore

United Kingdom

United ArabNetherlands Emirates

BerlinCambridge

Creating positive impact
By embedding our corporate social responsibility (CSR) strategy into business, we aredriving positive stakeholder impact and long-term sharehholder value.

Our recognition• 3BL 100 Best Corporate Citizens• AmCham Corporate and Societal Action: Recognition for Excellence inSingapore (CARES)• America’s Most JUST Companies by JUST Capital and CNBC
• Disability Equality Index, Best Places to Work for Disability Inclusion• Dow Jones Sustainability Indices• Fast Company’s Innovation by Design Awards for the NovaSeq XSeries (honoree)• Fast Company’s World Changing Ideas Awards for the NovaSeq X
Series (honoree)• Forbes America’s Best-in-State Employers• Forbes World’s Best Employers• Forbes World’s Top Companies for Women• IBO Gold Award for Design for the NovaSeq X Series• Military Times Best for Vets
• Newsweek America’s Greatest Workplaces for Diversity• Newsweek America’s Most Responsible Companies• TIME World’s Best Companies• U.S. News & World Report Best Companies to Work For

1. 2023 Annual Revenue provided in February 2024.
2. Wetterstrand KA. The Cost of Sequencing a Human Genome. National Human Genome Research Institute website.
https://www.genome.gov/about-genomics/fact-sheets/Sequencing-Human-Genome-cost. Updated November 1, 2021.
Accessed November 17, 2022.
3. $200 USD genome on NovaSeq X Series is delivered at list price on 25B flow cell. Data on file. Illumina, Inc. 2023.
4. Main campus locations currently include San Diego, Foster City, Hayward, UK Illumina Centre, Netherlands, and Singapore Woodlands.

M-GL-01040 v3.0